This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Mature T/NK-cell lymphomas, hilmo
C3_TNK_LYMPHOMA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
556 |
4. Check minimum number of eventsNone |
556 |
5. Include endpointsNone |
556 |
6. Filter based on genotype QC (FinnGen only) |
484 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF12
- Parent code in ICD-10
- C81-C96
- Name in latin
- Lymphomata T-cellularia peripherica et cutanea
Similar endpoints
↥List of similar endpoints to
Mature T/NK-cell lymphomas, hilmo
based on the number of shared cases.
Similar with more cases:
- Non-Hodgkin lymphoma, all, including Hilmo
- Primary_lymphoid and hematopoietic malignant neoplasms
- Liquid cancers
- Liquid cancers, including Hilmo
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 484 | 177 | 307 |
| Unadjusted period prevalence (%) | 0.11 | 0.06 | 0.14 |
| Median age at first event (years) | 66.54 | 66.08 | 66.81 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 506
- Matched controls
- 5060
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
31.0
311.3
241
144
C84.0
ICD-10 Finland
Mycosis fungoides
+∞
262.0
228
*
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
150.8
137
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
11.0
145.9
202
289
L03AA02
ATC
filgrastim; parenteral
18.8
133.1
114
77
XW000
NOMESCO Finland
Bone marrow biopsy
12.2
110.1
124
131
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
10.7
95.5
117
138
9700/3-C44.9
ICD-O-3
Mycosis fungoides of skin, NOS
+∞
91.5
85
*
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
+∞
89.3
83
*
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
87.0
81
*
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
44.5
86.4
52
13
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
32.0
86.2
57
20
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
13.8
82.8
82
70
L03AA13
ATC
pegfilgrastim; parenteral
10.1
75.4
94
112
WW500
NOMESCO Finland
Blood transfusion
9.7
74.7
96
119
JN6AD
NOMESCO Finland
CT of torso and neck
17.6
72.1
61
39
PJA10
NOMESCO Finland
Exploration of lymph nodes
20.2
70.8
56
31
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
8.2
69.4
104
155
JN4BD
NOMESCO Finland
Extensive body CT
5.8
67.6
157
364
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
32.0
66.8
44
15
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
20.9
65.7
51
27
L30.9
ICD-10 Finland
Dermatitis, unspecified
4.9
65.1
207
624
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
+∞
62.8
59
*
C84.5
ICD-10 Finland
Other mature T/NK-cell lymphomas
+∞
58.5
55
*
D07AB08
ATC
desonide; topical
5.3
54.4
133
318
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.0
51.2
62
70
D07AD01
ATC
clobetasol; topical
4.5
51.2
165
491
D05BB02
ATC
acitretin; oral
11.7
48.7
52
49
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.9
45.0
90
178
C10AB05
ATC
fenofibrate; oral
12.2
44.6
46
41
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
14.4
43.0
40
30
JN4AD
NOMESCO Finland
Body CT examination
4.2
41.0
134
397
C84.43
ICD-10 Finland
Peripheral T-cell lymphoma, large cell type
+∞
40.1
38
*
TQW80
NOMESCO Finland
Local dermatologic skincare
9.9
40.1
48
53
H02AB06
ATC
prednisolone; systemic
3.6
40.1
342
1870
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.8
39.8
81
162
D70.82
ICD-10 Finland
Drug-induced neutropenia
13.1
39.7
39
32
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
12.3
39.2
40
35
C84.41
ICD-10 Finland
Peripheral T-cell lymphoma, medium-sized cell type
+∞
39.1
37
*
E0000UV, ,
ATC
3.3
38.9
290
1453
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.1
38.7
134
412
R50.9
ICD-10 Finland
Fever, unspecified
3.8
38.2
149
498
A03FA01
ATC
metoclopramide; systemic, rectal
3.4
35.7
186
745
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
+∞
34.8
33
*
D07AC01
ATC
betamethasone; topical
3.1
34.6
262
1300
L26
ICD-10 Finland
Exfoliative dermatitis
176.1
32.1
33
*
127
Kela drug reimbursment
Transplant complication
12.6
31.9
32
27
M04AA01
ATC
allopurinol; systemic
3.5
31.9
143
517
A04AA01
ATC
ondansetron; systemic, rectal
4.3
30.8
89
237
9705/3-C77.9
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph node, NOS
+∞
30.5
29
*
C84.1
ICD-10 Finland
Sézary disease
+∞
30.5
29
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.8
29.6
58
111
E000001, ,
ATC
3.2
29.6
151
588
WW300
NOMESCO Finland
Transfer of autologic stem cells
51.9
28.8
34
7
9702/3-C77.9
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph node, NOS
+∞
28.4
27
*
9700/3-C44.5
ICD-O-3
Mycosis fungoides of skin of trunk
+∞
28.4
27
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
35.1
28.2
36
11
WW409
NOMESCO Finland
Other aferesis
50.2
27.8
33
7
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
56.7
27.5
32
6
D07AC13
ATC
mometasone; topical
2.8
26.1
201
972
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
9.6
25.9
31
34
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
24.1
25.6
36
16
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
32.0
25.3
33
11
J05AB11
ATC
valaciclovir; oral
3.2
25.1
118
434
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
32.9
24.0
31
10
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
8.6
23.7
31
38
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.8
23.2
33
45
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
+∞
23.1
22
*
XQ848
NOMESCO Finland
Dermatological photography
6.1
22.8
41
72
H02AB09
ATC
hydrocortisone; systemic
7.4
22.3
33
47
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.1
22.1
65
174
D02AE01
ATC
carbamide; topical
4.2
21.9
63
166
E000002, ,
ATC
3.5
21.7
83
267
A04AA02
ATC
granisetron; systemic, transdermal
4.0
21.4
66
183
L04AD01
ATC
ciclosporin; systemic
8.3
20.2
27
34
1XX25, ,
NOMESCO Finland
+∞
19.9
19
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
19.6
106
418
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
27.3
19.3
26
10
134
Kela drug reimbursment
General erythroderma
35.9
19.1
24
7
E000006, ,
ATC
4.1
19.0
56
150
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.7
18.8
36
67
H02AB07
ATC
prednisone; oral
2.9
18.5
104
418
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
18.4
310
2051
E000003, ,
ATC
4.7
17.6
42
95
WW402
NOMESCO Finland
Leucoferesis
186.3
17.6
18
*
D07AB02
ATC
hydrocortisone butyrate; topical
2.3
17.3
185
1007
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
18.2
17.1
26
15
ZX120
NOMESCO Finland
Intravenous
3.0
16.8
81
298
ZX196, ,
NOMESCO Finland
+∞
16.8
16
*
Z51.5
ICD-10 Finland
Palliative care
2.9
16.7
88
340
L03AA14
ATC
lipegfilgrastim; parenteral
7.6
16.7
24
33
L01AA02
ATC
chlorambucil; oral
27.3
15.7
21
8
9702/3-C77.8
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
15.7
15
*
L41.9
ICD-10 Finland
Parapsoriasis, unspecified
+∞
15.7
15
*
L04AX03
ATC
methotrexate; systemic
3.1
15.4
71
254
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
46.5
15.2
18
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
14.7
14
*
9700/3-C44.7
ICD-O-3
Mycosis fungoides of skin of lower limb and hip
+∞
14.7
14
*
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4.2
14.6
40
101
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
14.5
84
341
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
14.4
130
651
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
10.9
14.4
27
26
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.7
14.4
87
361
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
19.9
14.3
21
11
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
6.6
14.2
23
36
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.8
14.2
33
73
D07BA04
ATC
hydrocortisone and antiseptics; topical
3.0
13.9
65
234
J01MA12
ATC
levofloxacin; systemic
2.3
13.8
133
684
D02AX
ATC
Other emollients and protectives
5.2
13.7
29
59
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.3
13.5
23
38
TK800
NOMESCO Finland
Hemodialysis
5.5
12.9
25
47
L40.0
ICD-10 Finland
Psoriasis vulgaris
4.3
12.8
34
84
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.0
12.7
59
212
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.4
12.2
31
74
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.5
12.1
86
384
WW200
NOMESCO Finland
Immunization
5.2
12.1
25
50
D07AA02
ATC
hydrocortisone; topical
2.4
11.8
87
396
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.0
11.5
25
52
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
11.5
11
*
9702/3-C42.1
ICD-O-3
Mature T-cell lymphoma, NOS, of bone marrow
+∞
11.5
11
*
L41.8
ICD-10 Finland
Other parapsoriasis
122.7
11.5
12
*
J02AC01
ATC
fluconazole; systemic
2.0
11.3
173
1051
A41.9
ICD-10 Finland
Sepsis, unspecified
3.7
11.2
36
102
A02BC02
ATC
pantoprazole; systemic
2.0
11.0
367
2871
A07AA02
ATC
nystatin; oral
3.2
10.7
44
147
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
61.3
10.7
12
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
61.3
10.7
12
*
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
11.6
10.6
19
17
D07XC01
ATC
betamethasone; topical
2.4
10.6
81
373
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.9
10.5
51
187
H03AA01
ATC
levothyroxine sodium; systemic
2.1
10.5
123
675
L20.0
ICD-10 Finland
Besnier prurigo
3.4
10.5
39
122
9705/3-C77.8
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph nodes of multiple regions
+∞
10.4
10
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
12.4
10.4
18
15
B72
ICPC
Hodgkin Lymphoma
33.3
10.4
13
*
L30.3
ICD-10 Finland
Infective dermatitis
4.0
10.4
30
79
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.0
10.4
30
79
E000007, ,
ATC
3.4
10.1
37
115
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
40.9
10.0
12
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.0
9.9
20
23
L01CB01
ATC
etoposide; systemic
13.7
9.7
16
12
TGC00
NOMESCO Finland
Bronchial lavation
3.8
9.7
30
83
R06AE07
ATC
cetirizine; oral
1.8
9.7
202
1343
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
56.1
9.7
11
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
9.6
195
1285
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.0
9.6
136
798
L41.4
ICD-10 Finland
Large plaque parapsoriasis
101.9
9.4
10
*
QCA99
NOMESCO Finland
Other local destruction of skin of upper limb
+∞
9.4
9
*
9717/3-C17.9
ICD-O-3
Intestinal T-cell lymphoma of small intestine, NOS
+∞
9.4
9
*
9700/3-C44.6
ICD-O-3
Mycosis fungoides of skin of upper limb and shoulder
+∞
9.4
9
*
J05AB01
ATC
aciclovir; systemic
2.0
9.4
120
678
WF004
NOMESCO Finland
Palliative radiotherapy
4.4
9.2
23
54
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
24.5
8.9
12
5
JFB00
NOMESCO Finland
Partial resection of small intestine
7.0
8.9
21
31
D70.89
ICD-10 Finland
Neutropenic splenomegaly
7.9
8.7
19
25
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
8.6
59
258
A05AA02
ATC
ursodeoxycholic acid; oral
7.5
8.5
19
26
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
20.4
8.5
12
6
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
91.5
8.4
9
*
C84.42
ICD-10 Finland
Peripheral T-cell lymphoma, both medium and large cell type
+∞
8.4
8
*
C84
ICD-10 Finland
Mature T/NK-cell lymphomas
+∞
8.4
8
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
14.8
8.2
13
9
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
8.2
165
1074
S18
ICPC
Laceration/cut
1.7
8.2
260
1926
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.2
8.2
33
109
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
8.1
128
773
H02AB02
ATC
dexamethasone; systemic
2.2
8.1
73
360
ZXE00
NOMESCO Finland
One hour or less
1.7
8.1
197
1355
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.4
8.0
56
247
N02AA05
ATC
oxycodone; systemic
1.9
8.0
126
759
212
Kela drug reimbursment
Gout
4.4
8.0
20
47
L04AA06
ATC
mycophenolic acid; systemic
6.3
7.9
20
33
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
13.3
7.9
13
10
ZXC50
NOMESCO Finland
Cryotherapy
3.4
7.9
28
85
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
11.0
7.8
14
13
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
7.1
7.8
18
26
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
7.8
61
283
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.0
7.8
22
57
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.6
7.7
44
176
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
6.9
7.7
18
27
J01DB01
ATC
cefalexin; oral
1.9
7.6
408
3469
D69.5
ICD-10 Finland
Secondary thrombocytopenia
25.4
7.6
10
*
FM1FN
NOMESCO Finland
Heart function isotope examination
25.4
7.6
10
*
L04AA01
ATC
[U] ciclosporin
7.8
7.4
16
21
WZC30
NOMESCO Finland
Teaching
1.9
7.4
98
557
ZX112
NOMESCO Finland
Subcutaneous
3.9
7.3
21
55
C84.2
ICD-10 Finland
T-zone lymphoma
+∞
7.3
7
*
C83.52
ICD-10 Finland
T-lymphoblastic lymphoma or leukemia
+∞
7.3
7
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
7.3
7
*
C84.3
ICD-10 Finland
Lymphoepithelioid lymphoma
+∞
7.3
7
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
7.3
7
*
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
+∞
7.3
7
*
9701/3-C44.9
ICD-O-3
Sezary syndrome of skin, NOS
+∞
7.3
7
*
WZC00
NOMESCO Finland
Treatment plan or consultation
1.7
7.2
186
1292
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
7.2
45
189
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
30.5
7.2
9
*
RS340, ,
NOMESCO Finland
30.5
7.2
9
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
6.9
75
397
N05BB01
ATC
hydroxyzine; systemic
2.7
6.9
36
138
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.4
6.9
48
212
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.7
6.8
21
58
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3.4
6.8
24
73
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
40.6
6.8
8
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
40.6
6.8
8
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
22.9
6.7
9
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.3
6.7
50
228
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
6.7
74
395
D11AH01
ATC
tacrolimus; topical
12.5
6.6
11
9
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
6.6
117
728
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
7.0
6.6
15
22
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.4
6.5
18
34
N05CF01
ATC
zopiclone; oral
1.7
6.4
173
1206
1XC12, ,
NOMESCO Finland
70.7
6.4
7
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
70.7
6.4
7
*
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
14.5
6.4
10
7
J01MA14
ATC
moxifloxacin; systemic
2.2
6.4
54
259
WF002
NOMESCO Finland
Radical radiotherapy
2.4
6.4
45
200
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
18.3
6.3
9
5
GD6AD
NOMESCO Finland
CT of chest and neck
18.3
6.3
9
5
TQW99
NOMESCO Finland
Other minor procedure on skin
2.6
6.3
37
151
9702/3-C80.9
ICD-O-3
Mature T-cell lymphoma, NOS, of unknown primary site
+∞
6.3
6
*
C83.59
ICD-10 Finland
Lymphoblastic lymphoma of indeterminate type
+∞
6.3
6
*
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
+∞
6.3
6
*
C779, 9715, 3
ICD-O-3
+∞
6.3
6
*
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
27.0
6.2
8
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
27.0
6.2
8
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.1
6.2
62
318
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.6
6.2
35
140
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
7.8
6.2
13
17
ZX108
NOMESCO Finland
Inhalation
7.8
6.2
13
17
H26.3
ICD-10 Finland
Drug-induced cataract
10.2
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
123
81
19.74
145.99
4.9
3.4
28784.48
3167.13
u/ml
—
31
8
94
32
35.85
145.13
1.6
1.3
—
—
—
0
0
121
98
15.91
127.85
9.6
5.7
403.63
127.50
iu/ml
—
24
10
128
9
189.67
127.03
2.1
1.1
—
—
—
0
0
80
25
37.82
126.29
2.3
2.3
—
—
—
0
0
74
32
26.91
104.50
3.5
2.0
215.80
202.04
e6/l
0.14
59
27
72
33
25.27
99.32
3.5
1.9
558.02
519.31
e6/l
0.13
55
26
47
30
17.17
55.29
4.4
2.8
38.78
42.33
%
0.39
32
18
66
78
9.58
52.74
1.6
1.4
125.81
170.02
au/ml
1.34
16
21
53
51
11.49
48.97
3.5
1.6
—
—
—
0
0
50
48
11.45
46.22
3.6
1.6
—
—
—
0
0
63
83
8.53
46.04
3.7
1.7
—
—
—
0
0
79
135
6.75
45.77
3.9
1.5
—
—
—
0
0
74
130
6.50
41.61
3.7
1.5
—
—
—
0
0
149
498
3.82
38.17
5.0
2.8
72.54
67.87
e9/l
0.77
122
384
41
40
11.07
37.35
2.9
2.4
58.25
66.35
iu/ml
—
11
6
255
1220
3.20
36.34
6.9
3.0
323.03
361.84
umol/l
6.77
247
1066
198
821
3.32
35.91
9.8
3.6
0.79
0.82
mmol/l
2.63
192
783
396
2521
3.63
33.33
29.2
10.1
3.83
4.22
e9/l
2.92
371
2191
112
349
3.84
31.27
3.2
1.6
—
—
—
0
0
165
661
3.22
31.03
10.9
5.9
1.07
1.03
mmol/l
1.07
160
614
50
85
6.42
28.80
1.4
1.2
351.80
266.50
u/ml
0.63
30
40
37
47
8.41
27.60
4.1
1.5
—
—
—
0
0
37
47
8.41
27.60
4.1
1.5
—
—
—
0
0
37
47
8.41
27.60
4.1
1.5
—
—
—
0
0
66
153
4.81
27.10
2.2
1.2
—
—
—
0
0
35
46
8.10
25.37
1.6
1.4
—
—
—
0
0
59
137
4.74
24.11
2.1
1.5
—
—
—
0
0
38
62
6.55
22.69
2.1
1.7
—
—
—
0
0
80
245
3.69
22.53
1.8
1.8
1.65
1.55
g/l
0.35
72
219
51
115
4.82
21.55
2.5
1.5
—
—
—
0
0
326
2126
2.50
21.25
12.6
5.3
33.07
35.16
g/l
7.85
318
1993
40
77
5.55
20.19
7.9
6.1
11.73
11.44
mg/l
0.12
40
72
45
101
4.79
19.08
2.2
1.5
—
—
—
0
0
173
894
2.42
18.42
4.1
1.9
—
—
—
0
0
31
52
6.29
17.98
1.7
1.6
—
—
—
0
0
30
51
6.19
17.17
4.0
2.6
—
—
—
0
0
47
122
4.14
16.58
1.4
2.3
13.17
12.62
mg/l
0.13
39
113
346
2466
2.27
16.28
19.7
7.3
11.09
12.01
umol/l
0.69
341
2357
61
195
3.42
15.93
1.4
2.3
44.82
40.00
u/l
0.80
54
172
252
1595
2.16
15.90
8.3
3.7
2.34
2.35
mmol/l
0.72
243
1444
36
78
4.89
15.89
2.8
1.6
—
—
—
0
0
135
664
2.41
15.71
3.1
1.8
—
—
—
0
0
72
260
3.06
15.38
1.7
1.2
1980.14
277.71
u/ml
0.64
66
242
26
20
13.64
15.34
5.0
1.6
—
—
—
0
0
40
98
4.35
15.20
2.8
1.5
—
—
—
0
0
49
141
3.74
14.97
2.8
1.3
—
—
—
0
0
25
19
13.78
14.84
5.1
1.7
—
—
—
0
0
25
19
13.78
14.84
5.1
1.7
—
—
—
0
0
59
195
3.29
14.59
2.7
2.9
—
—
—
0
0
31
64
5.09
14.45
2.2
1.6
—
—
—
0
0
26
26
10.48
13.62
5.0
1.5
—
—
—
0
0
26
26
10.48
13.62
5.0
1.5
—
—
—
0
0
26
26
10.48
13.62
5.0
1.5
—
—
—
0
0
26
26
10.48
13.62
5.0
1.5
—
—
—
0
0
152
832
2.18
13.47
1.6
1.4
2.51
2.73
g/l
0.46
120
482
106
499
2.42
13.41
4.8
3.6
—
—
—
0
0
25
28
9.33
12.38
2.4
1.1
—
—
—
0
0
25
28
9.33
12.38
2.4
1.1
—
—
—
0
0
121
625
2.23
12.25
3.4
1.9
—
—
—
0
0
27
58
4.86
12.02
3.9
1.3
—
—
—
0
0
27
59
4.78
11.79
3.8
1.3
—
—
—
0
0
27
59
4.78
11.79
3.8
1.3
—
—
—
0
0
275
1930
1.93
11.77
22.5
12.4
0.00
0.00
e9/l
0.53
238
1576
27
60
4.70
11.55
3.9
1.3
—
—
—
0
0
27
60
4.70
11.55
3.8
1.3
—
—
—
0
0
27
60
4.70
11.55
3.9
1.3
—
—
—
0
0
319
2382
1.92
11.00
16.7
7.6
1.22
1.21
mmol/l
0.69
287
2050
90
430
2.33
10.88
3.1
2.0
373.66
395.36
nmol/l
0.39
85
404
107
557
2.17
10.49
9.6
3.1
6.02
8.92
umol/l
1.66
101
501
53
199
2.86
10.49
4.6
1.7
—
—
—
0
0
29
75
4.04
10.26
2.8
2.2
34.59
33.27
pg
1.50
29
75
51
193
2.83
9.95
1.5
2.7
0.41
1.13
g/l
0.82
45
171
20
23
9.00
9.87
2.5
1.0
—
—
—
0
0
20
23
9.00
9.87
2.5
1.0
—
—
—
0
0
283
2084
1.81
9.66
6.9
3.0
—
—
estimate
—
0
0
40
134
3.16
9.65
1.6
1.5
0.02
0.12
iu/ml
—
5
28
21
44
4.94
9.62
1.1
1.1
—
—
—
0
0
157
981
1.87
9.06
2.4
1.7
1.70
1.43
mg/l
0.65
138
777
392
3225
1.96
9.05
7.8
4.5
15.67
13.16
mm/h
2.07
384
2989
15
12
12.84
8.91
1.7
1.3
—
—
—
0
0
305
2331
1.78
8.86
16.5
16.7
1.28
1.31
inr
0.46
260
1956
20
29
7.14
8.62
7.8
4.3
1.43
0.93
%
0.77
20
29
46
179
2.73
8.52
2.3
1.6
—
—
—
0
0
75
370
2.21
8.32
6.5
3.5
4.97
5.16
kpa
1.31
75
353
95
514
2.04
8.30
5.8
3.6
1.17
1.84
mmol/l
0.89
85
436
36
127
2.98
7.97
1.6
1.4
—
—
—
0
0
12
8
15.32
7.75
2.6
1.4
—
—
—
0
0
172
1160
1.73
7.44
6.4
2.6
—
—
—
0
0
150
990
1.73
6.93
8.4
3.2
2.49
2.46
mmol/l
1.94
142
894
42
174
2.54
6.88
1.9
2.0
10.55
10.24
iu/ml
—
10
47
41
169
2.55
6.79
1.5
3.8
1.79
2.63
ratio
0.46
28
97
66
335
2.12
6.79
2.3
1.7
—
—
—
0
0
15
21
7.33
6.75
1.4
1.2
—
—
—
0
0
43
183
2.48
6.67
1.5
4.2
56.10
43.36
mg/l
0.40
33
156
43
183
2.48
6.67
1.6
4.2
73.11
88.53
mg/l
0.17
34
153
333
2741
1.63
6.18
9.3
5.6
6.66
6.80
mmol/l
0.80
324
2623
199
1453
1.61
6.09
3.5
2.7
66.52
63.18
u/l
0.07
187
1353
9
6
15.23
5.92
1.4
1.3
—
—
—
0
0
11
12
9.34
5.81
1.1
1.0
—
—
—
0
0
59
308
2.04
5.63
7.1
3.6
2.10
2.03
mmol/l
0.05
50
229
43
200
2.26
5.49
8.4
4.0
25.08
25.09
mmol/l
0.00
43
186
30
118
2.64
5.48
1.8
1.2
—
—
—
0
0
15
29
5.30
5.43
1.3
1.5
—
—
—
0
0
8
5
16.23
5.42
1.0
1.0
—
—
—
0
0
14
25
5.73
5.41
1.3
2.0
—
—
—
0
0
30
119
2.62
5.39
1.8
1.2
—
—
—
0
0
24
85
2.91
5.32
1.5
1.4
81.43
259.13
miu/ml
—
5
31
32
133
2.50
5.24
1.4
1.6
—
—
—
0
0
169
1235
1.55
4.94
2.7
2.3
3.20
3.00
mg/l
0.43
159
1067
78
467
1.79
4.94
2.9
2.5
0.19
0.21
g/l
0.77
73
433
14
29
4.93
4.84
1.3
1.5
—
—
—
0
0
63
359
1.86
4.67
3.7
4.1
96.32
89.77
ng/l
0.16
58
320
29
122
2.46
4.65
1.5
1.2
—
2.54
—
0
5
125
864
1.59
4.61
1.8
1.7
980.92
1197.53
nmol/l
1.91
103
641
7
5
14.17
4.58
1.1
1.2
—
—
—
0
0
342
2927
1.52
4.57
6.4
5.0
53.67
941.50
e6/l
—
6
56
212
1650
1.49
4.52
3.4
3.3
2211.21
1475.56
ng/l
0.50
197
1431
14
32
4.47
4.47
1.3
1.3
—
—
—
0
0
29
126
2.38
4.35
1.2
1.2
—
—
—
0
0
28
120
2.41
4.33
1.9
1.4
—
—
—
0
0
110
749
1.60
4.30
2.7
2.6
24.45
22.58
%
0.51
104
703
27
116
2.40
4.16
1.5
1.2
—
—
—
0
0
7
7
10.12
4.02
1.3
1.0
—
—
—
0
0
10
18
5.64
3.99
1.2
1.1
—
—
—
0
0
114
796
1.56
3.98
2.7
2.6
2.20
2.25
g/l
0.30
108
740
35
172
2.11
3.95
1.7
1.3
—
—
—
0
0
237
1923
1.44
3.91
2.7
2.5
75.29
77.00
nmol/l
0.42
219
1703
14
38
3.76
3.82
2.6
1.8
—
—
—
0
0
235
1912
1.43
3.78
3.8
3.0
544.40
153.69
ug/l
3.29
221
1764
6
5
12.12
3.77
1.0
1.0
—
—
—
0
0
187
1462
1.44
3.73
7.1
3.4
33.94
34.83
u/l
0.14
178
1380
120
859
1.52
3.73
2.8
2.7
12.80
12.63
umol/l
0.07
113
809
24
104
2.37
3.65
1.2
1.3
—
—
—
0
0
11
25
4.47
3.64
1.6
1.3
—
—
—
0
0
11
25
4.47
3.64
2.5
1.9
—
—
—
0
0
13
35
3.78
3.61
1.1
1.0
—
—
—
0
0
10
21
4.84
3.57
2.1
1.1
—
—
—
0
0
131
965
1.48
3.53
4.9
4.2
296.87
352.47
ng/l
0.11
111
816
11
26
4.30
3.52
2.5
1.9
—
—
—
0
0
12
31
3.94
3.51
2.3
1.8
—
—
—
0
0
201
1607
1.42
3.49
4.3
3.5
15.93
106.11
e6/l
1.54
160
1248
14
47
3.04
3.43
1.3
1.3
—
—
—
0
0
216
1754
1.40
3.41
4.9
4.2
106.61
151.12
e6/l
0.20
165
1283
20
86
2.38
3.12
1.4
1.3
—
—
—
0
0
20
86
2.38
3.12
1.4
1.3
—
—
—
0
0
87
604
1.53
3.09
9.3
8.8
4.75
5.11
kpa
2.72
80
585
87
605
1.53
3.07
9.3
8.8
11.35
11.76
kpa
0.44
80
589
27
134
2.07
3.02
3.4
3.3
3.17
2.07
index
0.42
12
83
9
21
4.34
3.00
3.0
5.3
—
—
—
0
0
20
89
2.30
2.90
1.9
1.4
32.94
27.24
iu/l
0.26
20
73
12
38
3.21
2.87
1.9
2.3
0.80
2.16
u/field
—
5
19
47
286
1.71
2.85
11.4
12.6
14.86
15.76
%
1.43
42
276
346
3094
1.37
2.78
6.2
4.1
14.70
14.99
pmol/l
1.33
325
2784
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
160
1.93
2.77
2.8
2.8
0.35
0.36
iu/ml
0.04
18
85
180
1459
1.36
2.74
2.2
2.2
125.26
277.68
u/l
2.21
175
1382
13
48
2.75
2.73
1.5
2.9
1125.00
1305.52
mg
0.10
13
48
171
1376
1.37
2.73
4.2
3.4
0.20
0.49
e6/l
2.66
134
1025
84
595
1.49
2.72
9.4
8.9
-0.27
0.87
mmol/l
1.26
63
498
12
40
3.05
2.71
1.5
1.2
—
82.00
—
0
5
143
1120
1.39
2.69
3.5
2.7
3.82
4.50
e6/l
0.62
130
1025
20
93
2.20
2.64
1.5
1.2
337.33
13.74
e6/l
0.58
15
70
36
208
1.79
2.62
3.0
3.6
3.92
4.38
pmol/l
1.72
31
186
8
20
4.05
2.57
1.8
3.7
204.88
202.80
u/l
—
8
20
5
7
7.20
2.55
3.2
2.3
38.60
36.57
u/l
—
5
7
107
805
1.42
2.53
3.7
3.2
4.32
1.76
e6/l
0.45
65
414
44
273
1.67
2.50
2.2
1.4
—
—
—
0
0
9
30
3.04
2.15
2.4
1.1
—
—
—
0
0
9
31
2.94
2.08
2.4
1.2
—
—
—
0
0
49
329
1.54
2.06
6.0
7.8
23.37
24.56
mmol/l
1.15
43
316
370
3961
0.75
2.04
7.4
7.1
39.67
40.05
mmol/mol
0.41
349
3688
5
11
4.58
1.94
1.2
1.1
—
—
—
0
0
7
22
3.21
1.88
6.4
2.4
124.14
98.14
%
—
7
22
6
17
3.56
1.84
1.2
1.1
—
—
—
0
0
6
17
3.56
1.84
1.7
1.7
47.55
70.56
ug/l
—
6
17
390
4130
0.76
1.83
6.9
6.2
2.61
2.57
mmol/l
0.41
366
3780
5
12
4.20
1.82
3.6
1.2
—
—
—
0
0
380
4035
0.77
1.79
6.2
5.3
1.31
1.42
mmol/l
5.49
358
3683
25
147
1.74
1.77
2.8
2.6
8.53
7.94
kpa
1.11
25
141
114
916
1.32
1.77
1.4
1.3
3.92
1.39
u/ml
0.62
30
239
216
1882
1.26
1.77
4.8
4.3
31.06
65.11
ng/l
0.67
175
1481
52
367
1.46
1.75
3.1
2.8
64.77
61.56
ml/min/173m2
0.22
22
155
6
18
3.36
1.75
1.0
1.1
10.10
9.32
ug/l
—
6
18
6
18
3.36
1.75
1.3
1.2
—
—
—
0
0
85
660
1.35
1.66
1.3
1.3
1.00
14.18
u/ml
3.93
34
228
18
98
1.87
1.63
2.3
2.6
14.99
16.00
%
0.92
18
92
5
14
3.60
1.62
1.0
1.1
—
—
—
0
0
20
114
1.79
1.58
1.8
1.5
—
—
—
0
0
33
217
1.56
1.56
1.2
1.2
57.67
116.66
u/ml
—
8
78
8
33
2.45
1.54
3.1
2.9
1.00
0.85
index
—
8
33
14
72
1.97
1.50
1.1
1.2
—
—
—
0
0
17
94
1.84
1.49
1.4
1.4
—
231.43
—
0
7
7
28
2.52
1.45
2.9
2.3
—
—
—
0
0
68
528
1.33
1.35
1.6
1.4
—
—
—
0
0
9
42
2.16
1.34
1.0
1.2
26.33
11.16
u/l
—
9
37
147
1696
0.81
1.33
4.3
4.8
21.20
21.54
%
0.10
66
861
15
254
0.58
1.29
2.9
1.8
—
—
—
0
0
104
861
1.26
1.28
3.7
3.1
1.11
1.03
e6/l
0.10
63
469
9
44
2.06
1.27
1.0
1.3
—
—
—
0
0
14
77
1.84
1.26
1.9
1.9
1.53
1.66
mmol/l
0.32
14
72
387
4055
0.81
1.24
7.3
5.4
4.44
4.44
mmol/l
0.05
368
3736
13
226
0.56
1.23
2.0
1.7
—
—
—
0
0
8
37
2.18
1.22
1.0
1.0
—
—
—
0
0
13
71
1.85
1.20
1.1
1.1
1.68
1.53
g/l
0.71
13
66
165
1451
1.20
1.15
2.0
1.8
18.06
20.31
nmol/l
1.37
146
1212
106
1247
0.81
1.14
3.0
3.4
0.61
0.79
ug/l
2.59
73
832
8
40
2.02
1.12
1.5
1.0
—
—
—
0
0
427
4416
0.79
1.12
63.4
27.8
218.18
240.06
e9/l
7.43
420
4331
12
66
1.84
1.10
1.0
1.3
—
—
—
0
0
11
59
1.88
1.08
2.2
3.2
64.80
21.59
mg/l
—
5
26
7
33
2.14
1.06
1.0
1.3
17.71
13.96
u/l
—
7
28
9
47
1.93
1.02
1.0
1.1
—
—
—
0
0
242
2220
1.17
1.01
3.3
2.6
—
—
—
0
0
428
4417
0.80
1.01
63.1
27.8
4.17
4.46
e12/l
18.18
421
4312
116
1001
1.21
0.98
1.9
1.8
600.20
18870628.18
pmol/l
0.69
99
832
5
23
2.19
0.98
1.2
1.7
0.62
0.91
nmol/l
—
5
16
9
50
1.81
0.97
1.0
1.1
—
—
—
0
0
85
714
1.23
0.94
1.3
1.3
27.43
37.08
iu/ml
0.24
26
217
6
27
2.24
0.93
1.2
4.3
83.83
95.81
nmol/l
—
6
27
230
2117
1.16
0.89
2.4
2.2
92.49
94.89
pmol/l
0.28
159
1135
142
1264
1.17
0.85
4.0
3.6
0.00
0.07
estimate
0.58
51
392
54
438
1.26
0.83
2.6
2.5
30.57
35.24
u/l
0.60
49
362
6
32
1.89
0.82
1.0
1.2
121.50
94.66
pmol/l
—
6
32
10
58
1.74
0.80
2.6
3.9
—
—
—
0
0
8
48
1.68
0.79
1.3
1.2
—
—
—
0
0
28
366
0.75
0.74
1.4
1.4
—
—
—
0
0
7
38
1.85
0.74
1.6
3.3
24.39
61.26
u/ml
—
7
38
374
3878
0.86
0.73
6.9
4.5
1.45
1.28
mmol/l
3.93
351
3514
391
4040
0.86
0.72
6.9
5.5
6.00
6.07
mmol/l
0.75
364
3674
251
2364
1.12
0.63
4.4
4.1
0.00
0.67
estimate
0.51
61
457
196
2098
0.89
0.60
4.8
5.9
2.30
2.71
ug/l
0.33
180
1874
245
2311
1.12
0.59
4.4
4.1
0.00
0.00
estimate
-0.00
66
485
63
543
1.18
0.57
2.0
4.5
3.42
35.25
ug/l
1.41
49
459
12
172
0.69
0.57
1.1
1.0
—
—
—
0
0
247
2335
1.11
0.57
4.4
4.1
0.01
7.12
estimate
0.80
67
492
5
86
0.58
0.56
1.6
2.0
—
—
—
0
0
388
3989
0.88
0.55
38.1
18.0
76.74
76.66
ml/min/173m2
0.02
376
3735
6
39
1.54
0.53
1.3
1.2
—
—
—
0
0
6
40
1.51
0.51
1.0
1.3
65.83
49.09
u/l
—
6
35
6
41
1.47
0.50
1.3
1.2
—
—
—
0
0
6
41
1.47
0.50
1.3
1.2
—
—
—
0
0
6
41
1.47
0.50
1.3
1.2
—
—
—
0
0
7
47
1.50
0.47
1.1
1.1
—
0.72
—
0
9
419
4276
0.88
0.46
47.1
22.5
3.98
4.01
mmol/l
1.08
413
4196
13
95
1.38
0.44
1.2
1.3
—
—
—
0
0
420
4112
1.13
0.43
45.8
18.4
26.74
26.65
mg/l
0.02
394
3462
282
2710
1.09
0.43
5.9
3.6
71.55
57.34
u/l
1.07
269
2532
5
32
1.57
0.42
1.4
1.3
150.60
159.32
pmol/l
—
5
32
188
1777
1.09
0.41
4.5
4.1
0.00
0.03
estimate
1.71
57
414
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
18
141
1.29
0.40
1.8
1.5
269.83
285.40
ug/g
0.15
12
81
7
101
0.69
0.40
1.7
2.0
—
—
—
0
0
13
97
1.35
0.40
3.2
4.1
19.10
28.62
mg/l
—
8
67
420
4272
0.90
0.36
46.2
22.3
138.97
139.64
mmol/l
5.29
414
4196
27
228
1.19
0.34
2.3
3.7
32.94
2090.16
u/ml
1.73
20
194
6
45
1.34
0.34
1.3
1.2
—
—
—
0
0
139
1313
1.08
0.31
4.8
4.1
0.00
0.00
estimate
0.50
57
438
17
138
1.24
0.31
1.6
1.3
—
—
—
0
0
7
55
1.28
0.30
1.1
1.3
0.66
0.60
nmol/l
—
7
48
7
56
1.25
0.29
1.1
3.4
3.39
6.76
nmol/l
—
7
56
385
3780
1.08
0.28
6.6
5.2
1.90
1.98
mu/l
0.69
366
3425
8
63
1.27
0.28
1.0
1.0
—
—
—
0
0
13
160
0.81
0.26
1.2
1.8
47.69
42.38
nmol/l
0.26
13
151
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
321.71
—
0
7
100
1051
0.94
0.20
4.8
4.3
1.02
1.02
kg/l
0.57
72
706
12
99
1.22
0.19
1.3
1.2
0.81
0.90
g/l
0.98
12
99
49
528
0.92
0.19
17.7
7.5
—
—
—
0
0
11
91
1.21
0.17
1.1
1.2
1.48
1.53
g/l
0.29
11
91
8
69
1.16
0.16
2.9
3.1
1.17
1.19
mmol/l
—
8
69
8
70
1.15
0.16
2.9
3.1
105.13
105.14
mmol/l
—
8
70
11
92
1.20
0.16
1.3
1.3
1.12
0.85
nmol/l
0.51
11
77
29
314
0.92
0.13
1.7
2.2
3.62
3.56
ratio
0.09
23
261
10
87
1.15
0.09
3.9
2.8
14.74
9.71
pmol/l
—
10
87
7
67
1.05
0.08
1.7
1.3
—
—
—
0
0
8
75
1.07
0.07
2.0
2.0
13.38
10.34
mmol/l
—
8
75
175
1776
0.98
0.07
2.6
2.0
1.51
1.31
mmol/l
2.30
158
1461
163
1655
0.98
0.07
4.0
4.1
8.45
8.94
mg/mmol
0.06
104
1045
60
583
1.03
0.06
5.1
5.2
28.57
31.92
%
2.00
49
368
43
445
0.96
0.05
1.6
1.7
1.49
1.60
%
0.43
37
382
35
361
0.97
0.03
1.8
1.4
—
—
—
0
0
18
189
0.95
0.03
1.4
1.6
0.34
0.38
mg/l
0.10
11
82
165
1659
0.99
0.01
3.1
3.4
7.28
7.76
mmol/l
0.93
135
1375
10
96
1.04
0.00
1.4
1.8
2.74
4.64
iu/l
—
5
35
10
97
1.03
0.00
1.2
1.1
—
2.87
—
0
13
0
6
0.00
-0.00
0.0
1.3
—
8.73
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
12.37
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
110.00
—
0
8
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
45.15
—
0
9
5
56
0.89
-0.00
2.4
5.5
322.80
350.84
umol/l
—
5
50
0
8
0.00
-0.00
0.0
1.0
—
28.59
—
0
8
0
5
0.00
-0.00
0.0
4.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
1.17
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_TNK_LYMPHOMA – Mature T/NK-cell lymphomas, hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).